InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 252655

Wednesday, 02/10/2016 10:14:02 PM

Wednesday, February 10, 2016 10:14:02 PM

Post# of 346714

..I've touched before on BergenBio but I find all this fascinating... and when did PPHM seem to have those back to back days of 30M shares was it? that just so happened in March of 2014 and this was about the time that ex-PPHM Longhen Zhou went from BerGenBio back over to NantBioscience (part of Nantworks..) but heck, what isn't part of Nantworks so many divisions over there.
...
..




I wouldn't want anyone to forget that Longhen Zhou was also part of the 11 authors below... CALICO is falling fast off of my initial favorites list to come on board and steer SS Peregrine right past other BP's... what a puzzle we have here : )


Luhrs and Parseghian...interesting duo and just so happened to notice that Parseghian has recent work with 11 authors and one of them at Peregrine ... hmmmmmm...

Pfizer and Allergan and ??? coming soon after Peregrine ? ... but then we have Zhou from Nant Bioscience owned by Patrick Soon-Shiong and hell... maybe they need a few big backers in order to afford to get a stake in Peregrine Pharmaceuticals

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118661335&txt2find=brigitte|phan|patent


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News